LEO Pharma Strengthens Its Commercial Organization
yahoo.com
finance
2022-06-02 11:00:00

BALLERUP, Denmark, June 02, 2022--(BUSINESS WIRE)--As part of LEO Pharma's transformation towards becoming a global leader in medical dermatology, the company today announced a refocused commercial structure to support building a more simple, agile, and competitive company.

The commercial responsibilities in the Global Leadership Team (GLT) are consolidated, thereby reducing the number of commercial members. This means that:

Region Europe+ and Region International are merged with Global Therapeutic & Value Strategy into a newly established role in the Global Leadership Team: Global Product Strategy & International Operations.
